• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchOncolytics Biotech
    Picture of Oncolytics Biotech logo

    ONCY — Oncolytics Biotech News Story

    $0.370.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapSucker Stock
    • Market Cap
      $48.51m
    • Enterprise Value
      $44.40m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • Discussion
    • ONCY Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    Discussion
    ONCY Dividends
    All News

    Marketpulse: Mcdonald's, Enteromedics, Oncolytics, Tranzyme

    Picture of Oncolytics Biotech logoOncolytics Biotech
    08/02/2013 14:25

    Recent news on Oncolytics Biotech

    See all news
    • Brief: Oncolytics Biotech Announces Clinical Supply Agreement To Evaluate Pelareorep In Combination With Loqtorzi In Squamous Cell Anal Carcinoma

      11/11/2026 21:46
    • Brief: Oncolytics Says Pelareorep Shows Durable Survival Benefit in Anal Cancer

      27/10/2026 14:33
    • Brief: Oncolytics Biotech Expects Final Cohort 4 Results Of Goblet Study In Q4 2026

      14/10/2026 15:36
    • Brief: Oncolytics Biotech® Secures Patent Protection To Late 2040S And Provides Intellectual Property Portfolio Update

      12/10/2026 23:20
    • Brief: Oncolytics Biotech® Aligns With FDA On Registrational Path For Second-Line Ras-Mutant Mss Colorectal Cancer

      18/08/2026 14:05

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.